Literature DB >> 23180288

The miRNAs of herpes simplex virus (HSV).

Le Sun1, Qihan Li.   

Abstract

Herpes simplex virus (HSV) is a group of common human pathogens with two serotypes HSV-1 and HSV-2. The prevalence of HSV is worldwide. It primarily infects humans through epithelial cells, when it introduces a latent infection into the nervous system. During viral latency, only a region known as the latency-associated transcript (LAT) is expressed. The discovery of HSV miRNAs helps to draw a larger picture of the infection and pathogenesis of the virus. This review summarizes miRNAs found in HSV-1 and HSV-2 so far. The functional studies of miRNAs in HSV to date indicate that they play a stage-specific role coordinated with viral proteins to maintain the virus life cycle.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23180288      PMCID: PMC8218115          DOI: 10.1007/s12250-012-3266-5

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  48 in total

Review 1.  MicroRNA in the immune system, microRNA as an immune system.

Authors:  Li-Fan Lu; Adrian Liston
Journal:  Immunology       Date:  2009-07       Impact factor: 7.397

2.  A herpes simplex virus transcript abundant in latently infected neurons is dispensable for establishment of the latent state.

Authors:  R T Javier; J G Stevens; V B Dissette; E K Wagner
Journal:  Virology       Date:  1988-09       Impact factor: 3.616

3.  Physical characterization of the herpes simplex virus latency-associated transcript in neurons.

Authors:  E K Wagner; G Devi-Rao; L T Feldman; A T Dobson; Y F Zhang; W M Flanagan; J G Stevens
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

Review 4.  Analytic review: Interleukin-6 in surgery, trauma, and critical care: part I: basic science.

Authors:  Randeep S Jawa; Sergio Anillo; Kristin Huntoon; Heinz Baumann; Mahmoud Kulaylat
Journal:  J Intensive Care Med       Date:  2011 Jan-Feb       Impact factor: 3.510

5.  Numerous conserved and divergent microRNAs expressed by herpes simplex viruses 1 and 2.

Authors:  Igor Jurak; Martha F Kramer; Joseph C Mellor; Alison L van Lint; Frederick P Roth; David M Knipe; Donald M Coen
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

6.  The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes.

Authors:  A J Vyse; N J Gay; M J Slomka; R Gopal; T Gibbs; P Morgan-Capner; D W Brown
Journal:  Sex Transm Infect       Date:  2000-06       Impact factor: 3.519

Review 7.  miRNAs in the pathogenesis of oncogenic human viruses.

Authors:  Zhen Lin; Erik K Flemington
Journal:  Cancer Lett       Date:  2010-10-12       Impact factor: 8.679

Review 8.  Ocular HSV-1 latency, reactivation and recurrent disease.

Authors:  Hassanain S Toma; Andrea T Murina; Raymond G Areaux; Donna M Neumann; Partha S Bhattacharjee; Timothy P Foster; Herbert E Kaufman; James M Hill
Journal:  Semin Ophthalmol       Date:  2008 Jul-Aug       Impact factor: 1.975

9.  MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs.

Authors:  Jennifer Lin Umbach; Martha F Kramer; Igor Jurak; Heather W Karnowski; Donald M Coen; Bryan R Cullen
Journal:  Nature       Date:  2008-07-02       Impact factor: 49.962

10.  HSV-1 miR-H6 inhibits HSV-1 replication and IL-6 expression in human corneal epithelial cells in vitro.

Authors:  Fang Duan; Jingyu Liao; Qiang Huang; Yuhong Nie; Kaili Wu
Journal:  Clin Dev Immunol       Date:  2012-04-09
View more
  16 in total

1.  Patterns of accumulation of miRNAs encoded by herpes simplex virus during productive infection, latency, and on reactivation.

Authors:  Te Du; Zhiyuan Han; Guoying Zhou; Grace Zhou; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-22       Impact factor: 11.205

2.  Herpes Simplex Virus 1 MicroRNA miR-H28 Exported to Uninfected Cells in Exosomes Restricts Cell-to-Cell Virus Spread by Inducing Gamma Interferon mRNA.

Authors:  Rongquan Huang; Jiaming Wu; Xusha Zhou; Haifang Jiang; Grace Guoying Zhou; Bernard Roizman
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

Review 3.  Herpesvirus latency.

Authors:  Jeffrey I Cohen
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

4.  miR-28-3p is a cellular restriction factor that inhibits human T cell leukemia virus, type 1 (HTLV-1) replication and virus infection.

Authors:  Xue Tao Bai; Christophe Nicot
Journal:  J Biol Chem       Date:  2015-01-07       Impact factor: 5.157

5.  Effect of Loss-of-function of the Herpes Simplex Virus-1 microRNA H6-5p on Virus Replication.

Authors:  Rongquan Huang; Xusha Zhou; Shuqi Ren; Xianjie Liu; Zhiyuan Han; Grace Guoying Zhou
Journal:  Virol Sin       Date:  2019-04-24       Impact factor: 4.327

6.  miR-H28 and miR-H29 expressed late in productive infection are exported and restrict HSV-1 replication and spread in recipient cells.

Authors:  Zhiyuan Han; Xianjie Liu; Xiaoqing Chen; Xusha Zhou; Te Du; Bernard Roizman; Guoying Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-01       Impact factor: 11.205

Review 7.  The use of microRNA by human viruses: lessons from NK cells and HCMV infection.

Authors:  Tal Goldberger; Ofer Mandelboim
Journal:  Semin Immunopathol       Date:  2014-09-19       Impact factor: 11.759

Review 8.  The Emerging Role of miRNAs in HTLV-1 Infection and ATLL Pathogenesis.

Authors:  Ramona Moles; Christophe Nicot
Journal:  Viruses       Date:  2015-07-20       Impact factor: 5.048

Review 9.  The Role of microRNAs in the Pathogenesis of Herpesvirus Infection.

Authors:  Diogo Piedade; José Miguel Azevedo-Pereira
Journal:  Viruses       Date:  2016-06-02       Impact factor: 5.048

10.  Oncolytic HSV-Infected Glioma Cells Activate NOTCH in Adjacent Tumor Cells Sensitizing Tumors to Gamma Secretase Inhibition.

Authors:  Yoshihiro Otani; Ji Young Yoo; Samantha Chao; Joseph Liu; Alena Cristina Jaime-Ramirez; Tae Jin Lee; Brian Hurwitz; Yuanqing Yan; Hongsheng Dai; Joseph C Glorioso; Michael A Caligiuri; Jianhua Yu; Balveen Kaur
Journal:  Clin Cancer Res       Date:  2020-03-05       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.